Associated Genetic Biomarkers


NCI Definition: A non-invasive or invasive cystic epithelial neoplasm that affects almost exclusively females. It is characterized by the presence of columnar mucin-producing epithelial cells and ovarian-type stroma formation. [1]

Pancreatic mucinous-cystic neoplasms most frequently harbor alterations in TP53, KRAS, RNF43, PIK3CA, and TMEM127 [2].

Most Commonly Altered Genes in Pancreatic Mucinous-Cystic Neoplasm

KRAS Mutation, KRAS Exon 2 Mutation, KRAS Codon 12 Missense, TP53 Mutation, and PIK3CA Mutation are the most common alterations in pancreatic mucinous-cystic neoplasm [2].

Top Alterations in Pancreatic Mucinous-Cystic Neoplasm

Disease Details

Pancreatic Mucinous Cystic Neoplasm
Cystic Tumor of the Pancreas
Pancreatic Mucinous-Cystic Neoplasm with an Associated Invasive Carcinoma
OncoTree Name
Mucinous Cystic Neoplasm
OncoTree Code


1. National Cancer Institute. NCI Thesaurus Version 18.11d. [2018-08-28]. [2018-09-21].

2. The AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discovery. 2017;7(8):818-831. Dataset Version 8. This dataset does not represent the totality of the genetic landscape; see paper for more information.

3. All assertions and clinical trial landscape data are curated from primary sources. You can read more about the curation process here.